Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Last $35.19 USD
Change Today -1.58 / -4.30%
Volume 248.6K
As of 8:10 PM 02/5/16 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

52 Discovery

Irvine, CA 92618

United States

Phone: 949-297-7000


Masimo Corporation, a global medical technology company, develops, manufactures, and markets noninvasive monitoring technologies. The company provides its products directly and through distributors and original equipment manufacturers (OEM) partners to hospitals, emergency medical service (EMS) providers, physician offices, veterinarians, long term care facilities, and consumers. The company’s core business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. The company developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor and the Radius-7 wearable wireless patient monitor. The company developed the Patient SafetyNet remote patient surveillance monitoring system, which allows up to 80 patients to be monitored simultaneously through a central station or remotely by care providers through their pagers or smart phones. The company’s solutions and related products are based upon its proprietary Masimo SET and rainbow algorithms. These technologies are incorporated into vairous product platforms depending on its customers’ specifications. In addition, the company provides its technologies to OEMs in a form factor. The company’s technology is supported by a substantial intellectual property portfolio that it has built through internal development and, to a lesser extent, acquisitions and license agreements. The company exclusively licensed from Cercacor Laboratories, Inc. (Cercacor) the right to OEM rainbow technologies and to incorporate rainbow technology into its products intended to be used by professional caregivers, including, but not limited to, hospital caregivers and alternate care facility caregivers. Products and Markets The company offers technologies that incorporate a monitor or circuit board and sensors, including proprietary single-patient use, reusable and rainbow ReSposable sensors and patient cables. In addition, it offers remote alarm/monitoring solutions, software and connectivity solutions. Circuit Boards Masimo SET MS Circuit Boards: The company’s Masimo SET MS circuit boards perform signal processing and other pulse oximetry functions incorporating the Masimo SET platform. The company’s MS circuit boards are included in its proprietary monitors for direct sale or sold to its OEM partners for incorporation into their monitors. Once incorporated into a pulse oximeter, the MS circuit boards perform data acquisition processing and report the pulse oximetry levels to the host monitor. The circuit boards and related software interface directly with its proprietary sensors to calculate arterial blood oxygen saturation level and pulse rate (PR). The company’s new generation boards include the MS-2003, MS-2011, MS-2013, and the new MS-2040, with a typical power consumption of approximately 45 milliwatts. Masimo rainbow SET MX Circuit Boards: The company’s next-generation circuit board is the foundation for its Masimo rainbow Pulse CO-Oximetry and rainbow Acoustic Monitoring platform, utilizing technology licensed from Cercacor. The MX circuit boards offer full functionality of the company’s rainbow technology for noninvasive measurements for total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and acoustic respiration rate (RRa), in addition to providing Measure-Through-Motion and Low-Perfusion oxygen saturation (SpO2), PR and perfusion index (PI) measurement capabilities of Masimo SET pulse oximetry. In September 2014, the company announced its new MX-5 OEM circuit board, a technology platform that utilizes approximately half the power of previously available rainbow circuit boards to deliver breakthrough rainbow Pulse CO-Oximetry noninvasive measurement performance. In addition to the lower power demands compared to previous rainbow technology boards, the MX-5 adds dynamic power utilization to scale the MX-5’s power draw based upon the combination of parameters being monitored to permit even longer battery runtimes. uSpO2 Cable/Board: The company’s SET technology-in-a-cable contains the low pow


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MASI:US $35.19 USD -1.58

MASI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CONMED Corp $36.39 USD -0.54
ICU Medical Inc $86.47 USD -2.56
LivaNova PLC $56.30 USD -2.65
Merit Medical Systems Inc $15.72 USD -0.49
NuVasive Inc $41.45 USD -2.98
View Industry Companies

Industry Analysis


Industry Average

Valuation MASI Industry Range
Price/Earnings 23.5x
Price/Sales 2.9x
Price/Book 6.6x
Price/Cash Flow 22.0x
TEV/Sales 2.4x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MASIMO CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at